SEIDENBERG BETH C reported 2 transactions at KYVERNA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Common Stock
Shares
+3.79M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+735.98K
Price / share
—
Trade value
—
% of position
Net shares
+4.52M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/12/2024 | C · Conversion | +3.79M | — | — | New position | 0.00 | 3.79M |
| Common Stock Indirect | 2/12/2024 | C · Conversion | +735.98K | — | — | New position | 0.00 | 735.98K |
| Total | +4.52M | $0.00 | ||||||
Series A-1 Redeemable Convertible Preferred Stock
Common Stock
967.19K shares
Shares
−4.40M
Strike price
Held after
0.00
Exercisable
—
Series A-2 Redeemable Convertible Preferred Stock
Common Stock
1.94M shares
Shares
−8.83M
Strike price
Held after
0.00
Exercisable
—
Series B Redeemable Convertible Preferred Stock
Common Stock
880.36K shares
Shares
−4.01M
Strike price
Held after
0.00
Exercisable
—
Series B Redeemable Convertible Preferred Stock
Common Stock
735.98K shares
Shares
−3.35M
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A-1 Redeemable Convertible Preferred Stock Indirect | Common Stock967.19K shares | 2/12/2024 | C · Conversion | −4.40M | — | 0.00 | |
| Series A-2 Redeemable Convertible Preferred Stock Indirect | Common Stock1.94M shares | 2/12/2024 | C · Conversion | −8.83M | — | 0.00 | |
| Series B Redeemable Convertible Preferred Stock Indirect | Common Stock880.36K shares | 2/12/2024 | C · Conversion | −4.01M | — | 0.00 | |
| Series B Redeemable Convertible Preferred Stock Indirect | Common Stock735.98K shares | 2/12/2024 | C · Conversion | −3.35M | — | 0.00 |